Pharmaceuticals / services Hotline:
About

About Us

Dedicated to be an exquisite specialized pharmaceutical research company

Wings with Innovation, Strength, Thinking and AspirationBeijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and authorized production for chemical innovative drugs and high-end generic drugs.Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liq...

MORE
NEWS

News

  • Company News
  • |
  • Industry News
2022-11-17

Luliconazole and posaconazole are launched into market

The synthesis pilots of Luliconazole and posaconazole are successfully completed.The key intermediates are available to international market from July 2013.

2022-11-17

Olopatadine hydrochloride tablets has been approved by China SF

Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and ...

2022-11-17

Voriconazole tablets has been approved by China SF

Our new formulation Voriconazole tablets (50mg and 200mg) has been approved by China SFDA on 24th Nov. 2021. The tablets registration certificate No. is H20213892 and H20...

More
2022-11-17

Center for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and

Issues Pertaining to ImpleCenter for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and Technical Review

2022-11-17

NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs

NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs As per the requirements of the Notice of the General Office of the State Counci...

More